More on CHRS
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net sales | 481.26M |
| Cost of goods sold | 219.53M |
| Gross profit | 261.73M |
| Occupancy and buying expenses | 81.34M |
| Selling, general, and administrative expenses | 137.78M |
| Depreciation and amortization | 14.21M |
| Gain from sale of office premises | 0 |
| Total operating expenses | 234.36M |
| Income/(loss) from operations | 27.38M |
| Other income | 348K |
| Gain on repurchases of 1.125% Senior Convertible Notes | |
| Interest expense | -3.14M |
| Income/(loss) before income taxes | |
| Income tax provision/(benefit) | 6.81M |
| Net income/(loss) | 17.77M |
| Basic net income/(loss) per share | 0.15 |
| Diluted net income/(loss) per share | 0.15 |
Entities mentioned with cHRS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Citi | View Related Stories »
- Show More...
